Cepheid opens first manufacturing unit in India to make TB testing cartridges

14 March 2023 | News

Through this investment, the company hopes to aid India in its goal of eradicating tuberculosis by 2025

Cepheid, an American molecular diagnostics company, has announced the launch of their first manufacturing unit in India at Mahadeva Kodigehalli, Bengaluru. The 77,000 square-foot facility will manufacture the company’s industry-leading Xpert tuberculosis (TB) testing cartridges for India and other countries. 

The facility was inaugurated by Dr K. Sudhakar, Minister for Health & Family Welfare and Medical Education, Govt. of Karnataka, and Laurent Bellon, Senior Vice President, Operations, Cepheid USA in the presence of Srinath Venkatesh, President, Danaher India and Ravikumar Venkataraman, Vice President, Danaher India Development Centre. 

The launch of the new manufacturing unit in India represents a significant milestone for Cepheid, as it strengthens the company's commitment to providing accessible and high-quality molecular diagnostic solutions to health care providers and patients in the region. 

The Cepheid manufacturing project in India was initiated in 2018 to support the dynamic India market. In line with the Government of India’s "Make in India" policy, the local manufacturing of components will make Cepheid's MTB (Mycobacterium tuberculosis) kits more accessible while strengthening the broader molecular diagnostics production capabilities in the country. 

Cepheid has almost 50,000 GeneXpert Systems installed globally, including systems across 35 states and union territories in India.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account